Skip to main content

Know before you go low or high with real-time blood glucose readings, trends and alerts.

1

Help prevent highs, alerting if you are trending high.

2

Help prevent lows, alerting if you are at low, or trending low.

17:00 12:00 Meal 1 6.5 mmol/L 2 5.2 mmol/L
12:00 17:00 Meal 6.5 mmol/L 5.2 mmol/L 1 2
Glucose levels mmol/L
Predictive alerts
Bolus calculator
Bolus insulin
Active insulin
Glucose levels mmol/L
Predictive alerts
Bolus calculator
Bolus insulin
Active insulin

Frequently asked questions

The MiniMed Go™ System brings together an ecosystem of smart tools that provide real-time insights and comprehensive reports to make it easier to manage life on MDI.

  • Instinct Go sensor is a real-time, glucose monitoring system indicated for the management of diabetes.
  • The InPen™ smart insulin pen is intended for single-patient use by people with diabetes for the self-injection of a desired dose of insulin. For people with diabetes who do not self-manage their diabetes, the use of InPen™ connected insulin pen should always be under the supervision of a caregiver.

InPen, when paired with Instinct Go sensor, made by Abbott, is indicated for people with diabetes ages 7 and up or ages 2-6 under the supervision of an adult caregiver. This sensor offers the following improvements:

  • Small and discreet2
  • 15-day sensor
  • One-hour warm-up period.

At this time, InPen™ diabetes smart insulin pen is Lilly Humalog®, Lilly Lyumjev®, Novo Nordisk NovoRapid®, Novo Nordisk Fiasp® and Novo Nordisk Insulin Aspart Injection, 3mL cartridges (300 units). The MiniMed Go™ system is designed to work with standard insulin pen needles.

Colour availability varies by region. At this time, within Europe, the following colours are available:

  • Blue InPen™ compatible with Novo Nordisk insulin cartridges
  • Grey InPen™ compatible with Lilly insulin cartridges

The MiniMed Go™ app has a wide range of compatibility with several Apple® and Android™ devices. You can find updated compatibility information here on our website. We recommend checking compatibility and switching off automatic operating system updates to ensure the best possible user experience.

InPen™ connected insulin pen is the first Smart  insulin pen that uses Bluetooth® technology and intelligence through an easy-to-use Smartphone app to help people administer correction and meal-time insulin doses.

As part of our MiniMed Go™ system, you can view CGM data in real time from your Instinct Go sensor by linking the app to your CareLink™ Personal account. At this time within Europe, CGM data from the Instinct sensor, Simplera™ CGM, Guardian™ Connect and Guardian™ 4 system can be viewed in the MiniMed Go™ app.

Your Healthcare Professional or MiniMed representative may provide training on the MiniMed Go™ system. Additional resources can be found at the MiniMed Diabetes Learning Hub.

Yes, multiple InPen™ Smart insulin pens can be synced with one app account.

Cartridges are not included with InPen™ smart insulin pen. Your Healthcare Professional will provide you with your prescription for your diabetes management supplies.

References

  1. MiniMed Go™ System User Guide. https://www.minimed.com/content/dam/documents/en-us/MiniMed-Go-US-appmanual.pdf (Accessed April 2026)
  2. Data on file, Abbott Diabetes Care, Inc.
  3. NovoPen® 5 User Guide. https://www.novonordisk.com/content/dam/nncorp/global/en/our-products/pdf/instructions-for-use/novopen-5/NovoPen5-UK.pdf (Accessed April 2026)
  4. Smith, MB, et al., Why CGM alone is not enough: low actionability of CGM alerts without considering impact of active insulin. 59th EASD Annual Meeting of the European Association for the Study of Diabetes. Diabetologia. 2023;10.1007/s00125-023-05969-6.
  • ^ Compared to standalone CGM therapy
  • * Proper pairing, connectivity, and settings required or incorrect dosing and serious injury can occur. See user guide for full details.
  • ** Less work by using the dose calculator.
  • § Simulated on real-world data from unspecified CGM devices
  • ~ vs CGM alerts, simulated on real-world data from unspecified CGM devices
  • # Among patient-applied sensors
  • 1.MiniMed Go™ System User Guide. https://www.minimed.com/content/dam/documents/en-us/MiniMed-Go-US-appmanual.pdf (Accessed April 2026)
  • 2.Data on file, Abbott Diabetes Care, Inc.
  • 3.NovoPen® 5 User Guide. https://www.novonordisk.com/content/dam/nncorp/global/en/our-products/pdf/instructions-for-use/novopen-5/NovoPen5-UK.pdf (Accessed April 2026)
  • 4.Smith, MB, et al., Why CGM alone is not enough: low actionability of CGM alerts without considering impact of active insulin. 59th EASD Annual Meeting of the European Association for the Study of Diabetes. Diabetologia. 2023;10.1007/s00125-023-05969-6.
  • ^ Compared to standalone CGM therapy
  • * Proper pairing, connectivity, and settings required or incorrect dosing and serious injury can occur. See user guide for full details.
  • ** Less work by using the dose calculator.
  • § Simulated on real-world data from unspecified CGM devices
  • ~ vs CGM alerts, simulated on real-world data from unspecified CGM devices
  • # Among patient-applied sensors

Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor.

Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional. Please note that the intended use of a product may vary depending on geographical approvals.

Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices.

MC-DBA-2600047@2026 MiniMed Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc.The sensor shape and appearance, Abbott and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under licence. Sensor image © 2026 Abbott TM. Third-party brands are trademarks of their respective owners